All Releases
| |
Theravance Announces New Employment Inducement Awards
Mar 1, 2010
|
20.8 KB |
|
| |
Theravance to Present at Investor Conferences in March 2010
Feb 25, 2010
|
21.0 KB |
|
| |
Theravance Reports Fourth Quarter and Full Year 2009 Financial Results
Feb 11, 2010
|
157.5 KB |
|
| |
Theravance to Report Fourth Quarter and Full Year 2009 Financial Results on February 11, 2010
Feb 3, 2010
|
11.6 KB |
|
| |
Theravance Announces New Employment Inducement Awards
Feb 1, 2010
|
11.1 KB |
|
| |
Theravance Announces Receipt of Additional FDA Communication Regarding Telavancin NDA for the Treatment of Nosocomial Pneumonia
Jan 28, 2010
|
33.1 KB |
|
| |
Theravance to Present at the 28th Annual J.P. Morgan Healthcare Conference
Jan 7, 2010
|
22.1 KB |
|
| |
Theravance to Present at the Deutsche Bank 2009 Biotech Boston Confab
Dec 2, 2009
|
22.1 KB |
|
| |
Theravance Announces New Employment Inducement Awards
Dec 1, 2009
|
20.1 KB |
|
| |
Theravance Announces That EMEA Has Completed the Validation Phase for the Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections
Nov 30, 2009
|
26.3 KB |
|
| |
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Nov 27, 2009
|
31.0 KB |
|
| |
Theravance and Astellas Announce the Commercial Launch of VIBATIV( TM ) (telavancin) in the United States
Nov 5, 2009
|
30.3 KB |
|
| |
Theravance to Present at the 18th Annual Credit Suisse Health Care Conference
Nov 3, 2009
|
22.0 KB |
|
| |
Theravance Announces New Employment Inducement Award
Nov 2, 2009
|
20.1 KB |
|
| |
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in Europe
Oct 28, 2009
|
28.9 KB |
|
| |
Theravance Reports Third Quarter 2009 Financial Results
Oct 27, 2009
|
156.3 KB |
|
| |
GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD
Oct 27, 2009
|
36.4 KB |
|
| |
Theravance Earns $20 Million Milestone Under Telavancin Collaboration Agreement
Oct 22, 2009
|
31.7 KB |
|
 |
Theravance to Report Third Quarter 2009 Financial Results on October 27, 2009
Oct 19, 2009
|
9.3 KB |
|
| |
SOUTH SAN FRANCISCO, CA/October 19, 2009 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the period ended September 30, 2009 after market close on Tuesday, October 27, 2009.
An accompanying conference call will be held at 5:00 p.m. Eastern Daylight Time. To participate in the live call by te...
|
|
Theravance Announces New Employment Inducement Award
Oct 1, 2009
|
8.9 KB |
|
| |
SOUTH SAN FRANCISCO, CA/October 1, 2009 -- Theravance, Inc. (NASDAQ: THRX) today reported that an equity award was made to one new employee. Pursuant to Nasdaq Marketplace Rule 5635(c)(4), the equity award was granted under the Theravance, Inc. 2008 New Employee Equity Incentive Plan, which the Board of Directors of Theravance adopted to fac...
|
|
|
